Simultaneous receptors neutral

Simultaneous receptors exist that can bind neutral and ionic guests. These types of receptors are large macrocycles, such as calixarenes, in which the ion is bound to the functional groups at the lower rim of the calixarene and the neutral (often solvent) molecule is encapsulated within the cavity of fhe bowl, e.g. tetramethoxy-p-f-butylcalix[4]arene (2.116). In the solid state, an Na ion is coordinated to the oxygen atoms of the lower rim of fhe calix[4]arene and the complex contains one molecule of toluene within the hydrophobic cavity (Figure 2.27). 

Vitamin B12 is special in as far as its absorption depends on the availability of several secretory proteins, the most important being the so-called intrinsic factor (IF). IF is produced by the parietal cells of the fundic mucosa in man and is secreted simultaneously with HC1. In the small intestine, vitamin B12 (extrinsic factor) binds to the alkali-stable gastric glycoprotein IF. The molecules form a complex that resists intestinal proteolysis. In the ileum, the IF-vitamin B 12-complex attaches to specific mucosal receptors of the microvilli as soon as the chymus reaches a neutral pH. Then either cobalamin alone or the complex as a whole enters the mucosal cell. 

The simultaneous binding of cations and neutral molecules can be achieved by different types of molecular hosts or assemblies. Traditional host molecules such as crown ethers and calixarenes can complex both a cation and neutral molecule within different receptor sites. Metallohosts, where a metal cation is an intrinsic part of the host assembly, can complex neutral molecules within... 

The next phase of our research is the design of bifunctional neutral receptors which contain both anionic and cationic binding sites and therefore are capable to complex simultaneously anionic and cationic species in apolar solvents. There are only a few examples known in the literature related to this subject. 

Forskolin, a stimulant of cAMP production, is also effective in releasing histamine the action of PACAP may combine both cAMP and Ca elevation. Although injection of PACAP appears to inhibit add secretion, simultaneous administration of somatostatin-neutralizing antibody turns this inhibition into stimulation. Hence, injected PACAP may stimulate both the D cell and ECL cell, a finding also found in in vitro nxidels. This D cell stimulation is presumably at a VIP receptor, whereas the stimulation of the ECL cell is at a PACAP receptor. 

---